Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04329962 · ClinicalTrials.gov registry record · NA
Metabolism and Absorption of Anthocyanins From Extract and Whole Blueberry Powder Confections in Healthy Adults
A NA study of Healthy Diet and Nutrition Aspect of Cancer, sponsored by Ohio State University Comprehensive Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT04329962: Active NA study of Healthy Diet and Nutrition Aspect of Cancer, sponsored by Ohio State University Comprehensive Cancer Center.
NCT04329962 is a NA study of Healthy Diet and Nutrition Aspect of Cancer that is active but no longer recruiting, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 12 participants, below the 36,123-participant average among 7 other Healthy Diet trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04329962, a NA study of Healthy Diet and Nutrition Aspect of Cancer, is active but no longer recruiting, sponsored by Ohio State University Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies how well a group of compounds found in blueberries called anthocyanins are absorbed into the body from 2 different types of blueberry confections (blueberry extract and whole blueberry powder). Blueberries contain several compounds which may be beneficial for human health and prevention of disease. These compounds can be consumed as part of a complex matrix in the whole fruit or also in a simplified matrix in the form of a fruit extract. Studying the absorption and metabolism of these compounds may help researchers understand how they influence health and disease, as well as determining the role of the food matrix on absorption of berry phytochemical.
Primary Outcome
Means +/- SD (standard deviation) will be used to express the results from acceptability tests, and differences in acceptability of the two confections will be determined using paired t tests using the SPSS statistical software package.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Dietary Intervention
- OTHER Blueberry Powder Food Product
Study Locations (1)
Ohio
- Ohio State University Comprehensive Cancer Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2018-05-08 |
| Est. Completion | 2026-07-10 |
| Phase | NA |
What the registry record for NCT04329962 still lists
NCT04329962 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 36,123-participant average among 7 other Healthy Diet trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Healthy Diet appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.
NCT04329962 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04329962 about?
NCT04329962 is a clinical study titled "Metabolism and Absorption of Anthocyanins From Extract and Whole Blueberry Powder Confections in Healthy Adults". This trial studies how well a group of compounds found in blueberries called anthocyanins are absorbed into the body from 2 different types of blueberry confections (blueberry extract and whole blueberry powder). Blueberries contain several compounds which may be beneficial for human health and prev...
What is the current status of trial NCT04329962?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2018-05-08. Estimated completion is 2026-07-10.
What conditions does trial NCT04329962 study?
This clinical trial studies the following conditions: Healthy Diet, Nutrition Aspect of Cancer.
What interventions are being tested in trial NCT04329962?
The interventions under investigation include: Questionnaire Administration (OTHER), Dietary Intervention (OTHER), Blueberry Powder Food Product (OTHER).
Who is sponsoring clinical trial NCT04329962?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04329962 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Diet
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Mitopure Challenge to Detect Levels of Urolithin A in Dried Blood Spots
RECRUITING · NA
-
Monell USDA Taste Test Study
ACTIVE NOT RECRUITING · NA
-
SNAP Fruit and Vegetable Incentive Program Digital Promotions for Farmers' Markets
COMPLETED · NA
-
The Effects of Added Sugar Intake on Brain Blood Flow and Hippocampal Function in Midlife Adults
COMPLETED · NA
-
Fruits and Vegetables Incentives Study
COMPLETED · NA
-
Baylor Infant and Toddler Biomarker of Nutrition Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI